AIM: To compare feasibility, accuracy, and safety of laparoscopy and laparotomy in surgical staging of early-stage ovarian and fallopian tubal cancer. METHODS: Outcomes of patients with stage I ovarian and fallopian tubal cancer who underwent complete surgical staging at Asan Medical Center, Korea between 2004 and 2007 were retrospectively evaluated. RESULTS: Nineteen patients were surgically staged through laparoscopy and 33 through laparotomy. There were no between-group differences in mean age, parity, body mass index, lymph nodes retrieved, or omentum specimen size, nor were there between-group differences in the percentage of patients who were postmenopausal, those referred for restaging, in the time interval to restaging, in those upstaged after surgery, or in those with intraoperative tumor rupture. The laparoscopy group had significantly shorter operating time (221 +/- 83 min versus 275 +/- 63 min, P = 0.012), less blood loss (240 +/- 228 mL versus 568 +/- 451 mL, P = 0.005), less transfusion requirement (5.3% versus 30.3%, P = 0.033), faster return of bowel movement (1.3 +/- 0.7 days versus 3.6 +/- 1.7 days. P < 0.001), and shorter postoperative hospital stay (8.9 +/- 6.1 days versus 14.5 +/- 5.6 days, P = 0.002) and time interval to adjuvant chemotherapy (12.8 +/- 4.9 days versus 17.6 +/- 8.3 days, P = 0.049). There were no postoperative complications requiring further management. After a median follow-up time of 17 months (range 1-44 months), there was no recurrence or death from disease in either group. CONCLUSION: Laparotomy and laparoscopy showed similar surgical staging adequacy and accuracy, and laparoscopy showed more favorable operative outcomes. Laparoscopy was safe for early-stage ovarian and fallopian tubal cancer, although follow-up time was relatively short.
AIM: To compare feasibility, accuracy, and safety of laparoscopy and laparotomy in surgical staging of early-stage ovarian and fallopian tubal cancer. METHODS: Outcomes of patients with stage I ovarian and fallopian tubal cancer who underwent complete surgical staging at Asan Medical Center, Korea between 2004 and 2007 were retrospectively evaluated. RESULTS: Nineteen patients were surgically staged through laparoscopy and 33 through laparotomy. There were no between-group differences in mean age, parity, body mass index, lymph nodes retrieved, or omentum specimen size, nor were there between-group differences in the percentage of patients who were postmenopausal, those referred for restaging, in the time interval to restaging, in those upstaged after surgery, or in those with intraoperative tumor rupture. The laparoscopy group had significantly shorter operating time (221 +/- 83 min versus 275 +/- 63 min, P = 0.012), less blood loss (240 +/- 228 mL versus 568 +/- 451 mL, P = 0.005), less transfusion requirement (5.3% versus 30.3%, P = 0.033), faster return of bowel movement (1.3 +/- 0.7 days versus 3.6 +/- 1.7 days. P < 0.001), and shorter postoperative hospital stay (8.9 +/- 6.1 days versus 14.5 +/- 5.6 days, P = 0.002) and time interval to adjuvant chemotherapy (12.8 +/- 4.9 days versus 17.6 +/- 8.3 days, P = 0.049). There were no postoperative complications requiring further management. After a median follow-up time of 17 months (range 1-44 months), there was no recurrence or death from disease in either group. CONCLUSION: Laparotomy and laparoscopy showed similar surgical staging adequacy and accuracy, and laparoscopy showed more favorable operative outcomes. Laparoscopy was safe for early-stage ovarian and fallopian tubal cancer, although follow-up time was relatively short.
Authors: Koji Matsuo; Erica J Chang; Shinya Matsuzaki; Rachel S Mandelbaum; Kazuhide Matsushima; Brendan H Grubbs; Maximilian Klar; Lynda D Roman; Anil K Sood; Jason D Wright Journal: Gynecol Oncol Date: 2020-05-10 Impact factor: 5.482
Authors: Alexander Melamed; Nancy L Keating; Joel T Clemmer; Amy J Bregar; Jason D Wright; David M Boruta; John O Schorge; Marcela G Del Carmen; J Alejandro Rauh-Hain Journal: Am J Obstet Gynecol Date: 2016-08-25 Impact factor: 8.661
Authors: Frederico S Falcetta; Theresa A Lawrie; Lídia Rf Medeiros; Maria Ines da Rosa; Maria I Edelweiss; Airton T Stein; Alice Zelmanowicz; Anaelena B Moraes; Roselaine R Zanini; Daniela D Rosa Journal: Cochrane Database Syst Rev Date: 2016-10-13
Authors: Farr R Nezhat; Shaghayegh M Denoble; Jennifer E Cho; Douglas N Brown; Enrique Soto; Linus Chuang; Herbert Gretz; Prakash Saharia Journal: JSLS Date: 2012 Oct-Dec Impact factor: 2.172